Andere Sprachen Day One Biopharmaceuticals, Inc.

Aktien

A3CQ56

US23954D1090

DAWN

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 26.04.2024			% 5 Tage	% 1. Jan.
14.92 ^USD	+12.94%		-0.27%	+2.19%

24.04.	DAY ONE BIOPHARMACEUTICALS, INC. : Needham & Co. bleibt bei seiner Kaufempfehlung	ZM
24.04.	Transcript : Day One Biopharmaceuticals, Inc. - Special Call

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Day One Biopharmaceuticals : Corporate Presentation - April 2024	24.04.
Day One’s OJEMDA™ (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumor	23.04.
Day One’s OJEMDA™ (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG), the Most Common Form of Childhood Brain Tumor	23.04.
Day One's OJEMDA (tovorafenib) Receives US FDA Accelerated Approval for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma	23.04.
Day One Biopharmaceuticals Shares Rise; FDA Issues Accelerated Approval for Pediatric Low-Grade Glioma Treatment	23.04.
Day One Biopharmaceuticals Drug Tovorafenib Gets FDA Accelerated Approval	23.04.
Day One Biopharmaceuticals Insider Sold Shares Worth $322,166, According to a Recent SEC Filing	29.02.
Day One Biopharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	26.02.
Day One Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Progress	26.02.
Day One Biopharmaceuticals, Inc. Announces Executive Changes	26.02.
Day One Announces Two New Appointments to Board of Directors	17.01.
Day One Biopharmaceuticals, Inc. Announces Board Appointments	17.01.
Day One to Present at the 42nd Annual J.P. Morgan Healthcare Conference	19.12.
Day One Announces Tovorafenib FIREFLY-1 Data Published in Nature Medicine	17.11.
Day One Announces Tovorafenib FIREFLY-1 Data Published in Nature Medicine	17.11.
Day One Biopharmaceuticals : Change in Certifying Accountants - Form 8-K	15.11.
Day One to Participate in the Piper Sandler 35th Annual Healthcare Conference	14.11.
Day One Biopharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	06.11.
Day One Reports Third Quarter 2023 Financial Results and Corporate Progress	06.11.
Day One Reports Third Quarter 2023 Financial Results and Corporate Progress	06.11.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Day One Biopharmaceuticals, Inc.

Aktien

A3CQ56

US23954D1090

DAWN

Andere Sprachen

Filter